Pharma Journalist -

Ocular Therapeutix, Inc. announced that it has dosed the first patients in its Phase 1 clinical trial of OTX-CSI (cyclosporine intracanalicular insert) for the treatment of dry eye…
Read More...

Bellerophon Therapeutics, Inc. announced that the U.S. Food and Drug Administration (FDA) accepted its Investigational New Drug (IND) application, allowing the Company to initiate a…
Read More...

Themis, a clinical-stage biopharmaceutical company focused on immunomodulation therapies for infectious diseases and cancer, and ABL Europe (ABL), a global Contract Development and…
Read More...

CRISPR Therapeutics and Vertex Pharmaceuticals Incorporated announced that the U.S. Food and Drug Administration (FDA) granted Regenerative Medicine Advanced Therapy (RMAT) designation…
Read More...

AstraZeneca and Daiichi Sankyo Company, Limited (Daiichi Sankyo)’s Enhertu (trastuzumab deruxtecan) has been granted Breakthrough Therapy Designation (BTD) in the US for the treatment…
Read More...

Dyno Therapeutics, Inc., a biotechnology company applying artificial intelligence (AI) to gene therapy, announced the company’s launch from stealth mode with its proprietary platform,…
Read More...

Acer Therapeutics Inc. announced it has entered into a research collaboration agreement with the National Center for Advancing Translational Sciences (NCATS), one of the National…
Read More...

SMi reports: Nagy Habib, Professor of Surgery and Co-founder of MiNA therapeutics will chair and present at this year’s Oligonucleotide Therapeutics and Delivery Conference, which will…
Read More...

Healthcare professionals need to stay aware of the latest digital health activities and keep learning from leading organizations. Digital Health Online Summit is a 6-day virtual…
Read More...

The U.S. Food and Drug Administration has issued the first emergency use authorization (EUA) for a COVID-19 antigen test, a new category of tests for use in the ongoing pandemic. These…
Read More...